Aura Biosciences, Inc. (AURA) Financials
AURA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 137.7 million | 30.4 million |
| Dec. 31, 2025 | 169.4 million | 32.5 million |
| Sept. 30, 2025 | 190.0 million | 33.4 million |
| June 30, 2025 | 204.4 million | 29.8 million |
AURA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -30.0 million | 3.8 million |
| Dec. 31, 2025 | -20.6 million | 3.3 million |
| Sept. 30, 2025 | -20.2 million | 3.7 million |
| June 30, 2025 | -20.8 million | 3.8 million |
AURA Net Income
No data available :(
AURA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 114.7 million | 13.7 million | 17.0 million |
| Dec. 31, 2025 | 144.2 million | 14.1 million | 17.4 million |
| Sept. 30, 2025 | 161.9 million | - | 17.8 million |
| June 30, 2025 | 177.3 million | - | 18.1 million |
AURA Shares Outstanding
AURA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 102000 | 28.0 million | 6.9 million | - |
| Dec. 31, 2025 | 176000 | 21.9 million | 5.3 million | - |
| Sept. 30, 2025 | 45000 | 22.2 million | 5.7 million | - |
| June 30, 2025 | 39000 | 22.9 million | 5.7 million | - |
AURA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 274000 |
| Dec. 31, 2025 | - | -600000 |
| Sept. 30, 2025 | - | 300000 |
| June 30, 2025 | - | 300000 |
AURA
Price: $7.05
52 week price:
Earnings Per Share: -1.71 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 120900
Market Capitalization: 496.9 million